Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Melatonin | Saw Palmetto (Serenoa repens) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision) | 320mg daily (standardized to 85-95% fatty acids and sterols) |
| Timing | 30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking. | With food (fat-soluble lipophilic extract). Morning or evening. |
| Cycle Duration | Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision | Minimum 3 months to assess response; ongoing for maintenance |
| Evidence Level | strong_human | moderate_human |
Melatonin (N-acetyl-5-methoxytryptamine) is synthesized from serotonin in the pineal gland, regulated by the suprachiasmatic nucleus (SCN) via the retinohypothalamic tract. It binds MT1 and MT2 G-protein coupled receptors: MT1 activation suppresses neuronal firing in the SCN (sleep onset), while MT2 modulates circadian phase shifting. Beyond sleep, melatonin is a potent antioxidant that scavenges hydroxyl radicals, peroxynitrite, and singlet oxygen, and upregulates antioxidant enzymes (GPx, SOD, catalase) via Nrf2. It has anti-inflammatory properties (NF-kB suppression), immunomodulatory effects, oncostatic activity (anti-proliferative in several cancer types), and mitochondrial protective functions.
0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision)
30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking.
Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision
Saw palmetto berry extract contains fatty acids (lauric acid, oleic acid, myristic acid) and phytosterols (beta-sitosterol) that inhibit both isoforms of 5-alpha-reductase (types I and II), reducing conversion of testosterone to dihydrotestosterone (DHT). It also exhibits anti-androgenic activity by competing with DHT at androgen receptor binding sites. Additional mechanisms include: inhibition of cyclooxygenase and 5-lipoxygenase (anti-inflammatory in prostate tissue), induction of apoptosis in prostate epithelial cells, and relaxation of bladder smooth muscle via alpha-1 adrenergic receptor antagonism.
320mg daily (standardized to 85-95% fatty acids and sterols)
With food (fat-soluble lipophilic extract). Morning or evening.
Minimum 3 months to assess response; ongoing for maintenance
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →